Cargando…
Synergistic Association between Plasma Aβ(1–42) and p-tau in Alzheimer’s Disease but Not in Parkinson’s Disease or Frontotemporal Dementia
[Image: see text] Beta-amyloid (Aβ(1–42)) triggers the phosphorylation of tau protein in Alzheimer’s disease (AD), but the relationship between phosphorylated tau (p-tau) and Aβ(1–42) in the blood is not elucidated. We investigated the association in individuals with AD (n = 62, including amnesic mi...
Autores principales: | Chiu, Ming-Jang, Yang, Shieh-Yueh, Chen, Ta-Fu, Lin, Chin-Hsien, Yang, Fu-Chi, Chen, Wen-Ping, Zetterberg, Henrik, Blennow, Kaj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278807/ https://www.ncbi.nlm.nih.gov/pubmed/33825443 http://dx.doi.org/10.1021/acschemneuro.1c00010 |
Ejemplares similares
-
Relevance of plasma biomarkers to pathologies in Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia
por: Chiu, Pai-Yi, et al.
Publicado: (2022) -
CSF sTREM2 in delirium—relation to Alzheimer’s disease CSF biomarkers Aβ42, t-tau and p-tau
por: Henjum, Kristi, et al.
Publicado: (2018) -
Sex influences clinical phenotype in frontotemporal dementia
por: Pengo, Marta, et al.
Publicado: (2022) -
Plasma tau is increased in frontotemporal dementia
por: Foiani, Martha S, et al.
Publicado: (2018) -
Plasma Levels of Aβ42 and Tau Identified Probable Alzheimer’s Dementia: Findings in Two Cohorts
por: Lue, Lih-Fen, et al.
Publicado: (2017)